Physician

Orthopaedic Surgery

Dr. Mark E. Elzik, MD


Mark E. Elzik practices Orthopaedic Surgery. He studied medicine at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is one of the top medical schools in the US. University of North Carolina at Chapel Hill School of Medicine is ranked 22/2 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Mark E. Elzik, MD is a published doctor. He published 5 publications, including: 'Kyphectomy in the treatment of patients with myelomeningocele.' Doctor Mark E. Elzik, MD accepts Medicare.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1093904302
NPPES Provider LastName   ELZIK
NPPES Provider FirstName   MARK
NPPES Provider ZIPCode   926916364
NPPES Provider State   CA
Specialty Description   Orthopedic Surgery
Total Claim Count   26.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1093904302
Last Name Of The Provider ELZIK
First Name Of The Provider MARK
View All

Similar Doctors


Dr. Brinceton M. Phipps, MD
This Doctor is OpenDoctor Recommended.
Dr. Kent S. Marangi, MD
This Doctor is OpenDoctor Recommended.
Dr. Mark J. Legome, MD
This Doctor is OpenDoctor Recommended.
Dr. John R. Morris, MD
This Doctor is OpenDoctor Recommended.
Dr. William E. Schobert, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Alan M. Strizak, MD
This Doctor is OpenDoctor Recommended.
Dr. Kenneth J. Wilkens, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Gonzalo A. Covarrubias, MD
Dr. Kent R. Adamson, MD
This Doctor is OpenDoctor Recommended.
Dr. William E. Schoebert, MD
Dr. Richard J. Claveria, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog